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Introduction 
In 1982 the Council for International Organisa-
tions of the Medical Sciences (CIOMS) published 
proposed International Guidelines for Biomedical 
Research Involving Human Subjects 1. The gui-
delines dealt mainly with the ethical issues sur-
rounding clinical trials and other types of research 
involving individual human volunteers. Since 1990 
the CIOMS has been working on a similar set of 
guidelines more directly related to research on 
groups and communities 2. The working group, 
under the able chairmanship of Professor John 
Last, has reached its fifth draft revision which, if 
approved by the Advisory Committee on Medical 
Research, will be circulated to national research 
granting agencies and similar bodies. It is prema-
ture at this stage to comment on the content and 
wording of the guidelines, but there are certain 
ethical considerations, already published elsewhere 
1, which are of particular relevance to research in 
countries such as Malawi. 
Objectives 
The objectives of the guidelines are to "inform 
lay members of ethical review committees, investi-
gators, students and others" and to "assist the de-
velopment of national standards for ethical review 
of epidemiological studies" 2. They are not, as Last 
says "carved in stone, but written in sand that shifts 
with the tides of human values, advancing medical 
science and changing health problem." Whether 
the guidelines achieve their objectives depends, of 
course, on their acceptability and utility, and this 
will only emerge with time. That they are needed 
at all is beyond argument, when so much research 
is developed and funded outside the set of cultural 
values and expectations in which it is carried out. 
Any honest attempt to make explicit the ethical 
principles on which research proposals and acti-
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vities should be judged, and to stimulate the mech-
anism for doing so is surely commendable - even if, 
in the way of many international guidelines, the 
wording ends up a little clumsy, and falls short of 
satisfying the moralists in any culture. ' 
Principles 
The guidelines derive (inevitably?) froto a loosely 
conceived Greek:Judeo-Christian-Uberal tradition 
of thought, with too little input from the cultures 
of the developing world. It is much easier, of 
course, to interpret conceptual meanings from a 
long history of written philosophical debate than 
from cultures with equally valued beliefs held in 
oral tradition. It might be argued, for instance, that 
cultural differences in the perception of individual 
autonomy jeopardize a universal understanding of 
"informed consent'; or that differing concepts of 
the importance of past and future vitiate shared 
ideas of 'risk'. There is no way the guidelines can 
deal adequately with such issues, so they take their 
starting point far to the right of philosophical de-
bate, in the three commonly accepted, utilitarian 
principles of medical ethic. If, to some, this seems 
to be dodging the main issue, it does at least avoid 
the arguments of the utilitarians and deontologists 
4 among ethicists, as well as steering reasonably 
clear of situational ethics. The three principles are 
respect for persons, beneficence and justice; and it 
is some of the issues surrounding these that it is 
worth looking at in the Malawian context. 
Respect For Persons 
The concept embraces 'autonomy' - the right of 
individuals and communities capable of setting up 
their own value systems to have their goals and 
decisions respected; and 'protection' - the right of 
individuals and communities not fully autonomous 
to be protected from exploitation. An autonomous 
individual or community has an absolute right to 
adequate information and to the whole truth about 
a study; this is the only legitimate framework for 
informed consent. Groups or individuals without 
full autonomy - children, prisoners etc. - are pro-
tected from being used in studies which would, 
scientifically, be equally suitable using autonomous 
in~ividuals or groups. For all with diminished au-
tonomy, proxy consent by a parent or guardian may 
be allowed, so long as the consent is freely given, 
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tion of the dependant individual or group is _of first 
concern. 
Individual informed consent remains para-
mount, but where group agreement is culturally 
important, as often in Malawi, this too must be 
sought. In this case, researchers must consider 
carefully whether leaders appointed by agencies, 
such as governments, outside the group express the 
collective will, and to seek if ne~essary a more 
'creditable representative'. "In all cases where it is 
proposed not to seek consent from subjects whose 
identities will be known, or discernible. an epidemi-
ologist must be prepared to defend his proposal to 
an appropriate ethical review committee, or more 
than one" I. 
Beneficence (And Non-maleficence) 
Beneficence - to strive for tht; greatest good, and 
non-maleficence - to do no harm, have connotation-
s for communities as well as for individuals. Thus, 
a study does harm when it violates community 
expectations, when it diverts the energies of scarce 
local health service workers, or when health care 
priorities are changed without a community's agree-
ment. Harm is done when groups within a com-
munity are stigmatized, lose their self-esteem, or their 
faith in others by raising discomforting suspicions. 
If, for instance, a study found a high level of gonor-
rhoea among secondary schoolboys in an unident-
ified school, a community might easily come to 
believe that all school boys were so infected. 
The principle of beneficence is usually served if 
a study has a sound scientific design and is con-
ducted by competent researchers able to assure the 
well-being of their subjects and to demonstrate to 
an independent review panel that expected benefits 
far outweigh anticipated risks. 
Justice 
Justice, apart from reinforcing the rights of the 
individual and community to informed decision 
making and protection from harm, also has an 
important distributive element. New knowledge 
must benefit the same sort of people who took part 
in the research, and those who benefit must bear a 
due share of the risks and burdens of the study. 
Weaker members of a community should not be 
the subjects of a study if all members are intended 
to benefit. It would be wrong for instance to do 
drug trials with their attendant risks, using groups 
who could never benefit from them because of cost 
or govenunent policy. 
Principles of justice also penetrate the realms of 
pUblication and dissemination of results. Com-
munities must be told in advance of the uses to 
which findings will be put, and how their privacy 
will be safeguarded; and, if there are benefits in the 
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results, the way these benefits will reach them in 
heal.th education, policy changes or improved ser-
vices. In this way, too, individual anxieties raised by 
the study about personal health status can partially 
be overcome; a well-planned, well accepted mess-
age about steps to be taken in the event of certain 
signs and symptoms etc. may discharge the duty. 
Justice demands, too, that a community take an 
active part in planning and implementing the study 
and that individuals within the community are not 
initially approached by strangers but by local health 
providers, or others, familiar with their situations 
and anxieties. And lastly it demands that if epidemi-
ologists argue the public benefit to justify privileged 
access to information, they should make their find-
ings public: This applies equally to those employed 
by government, international, institutional and pri-
vate sector agencies, who should all anticipate and 
plan to prevent or reduce partial, distorted or 
misconstrued releases of information. 
Discussion 
That is enough to give some pointers to what are, 
or will be, a very comprehensive and very useful set 
of guidelines. Almost every point they make is 
locally arguable, but it is as much in stimulating 
debate as in achieving blanket agreement that their 
importance lies. There are however three ideas that 
are much stressed and that are not covered by the 
three principles outlined above. 
The first is the independence of ethical review 
committees, on which the guidelines lay continual 
emphasis. The second is the material and other 
benefits that a society can reasonably expect to 
accrue as a result of any study, be they an improve-
ment in some aspect of health care, some diagnos-
tic facility, or the training of personnel in clinical 
technique or data analysis. And the third is the 
hope that the guidelines will be applicable to all 
who look at, or collect data, in an 'epidemiological' 
way, and not merely to those designated 'epidemi-
ologists'. 
For any single COll\l1lentator, least alone non-Ma-
lawian, to draw out the implications any further at 
this stage would be both impertinent and prema-
ture. Suffice to say that when the guidelines are 
generally available they will be more than enough 
for debate; and the interests of the people of Ma-
lawi will be best served if that debate is wide, open 
and free. 
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